IL1B and neoplasm: Interestingly, studies have shown that the release of bioactive IL-1β within tumours does not depend on the activation of inflammasomes, caspase-8, the pore-forming protein GSDMD, or mixed lineage kinase domain-like protein (MLKL) [160].